BNET Industries

Sequenom Inc.

Market Cap:$251.1M
Last Fiscal Year Sales:$47.1M
  • Public
  • US
Dow Jones Description

We are a genetics company committed to providing genetic analysis products, services and diagnostic applications. Our products and services are designed to translate the results of genomic research into solutions for biomedical research, translational research, molecular medicine applications and research conducted in the agro (agricultural and livestock) industry. Our development efforts in various diagnostic applications include areas of noninvasive diagnostics in prenatal, oncology and infectious diseases and other disorders. Our proprietary MassARRAY system, comprised of hardware, software applications, consumable chips and reagents, is a high performance (in speed, accuracy and cost efficiency) nucleic acid analysis platform that quantitatively and precisely measures genetic target material and variations. Our MassARRAY research and development efforts are committed to producing new and improved components and applications that deliver greater system versatility and reduce the cost per data point generated. MassARRAY technology is widely accepted as a leading high-performance DNA analysis platform for the fine mapping genotyping and quantitative gene expression markets and is gaining traction in new developing markets, such as epigenomics and pathogen typing. Our customers include some of the worldwide premier clinical research laboratories, biotechnology companies and academic institutions, as well as various government agencies. ...

Number of Employees 248
Contact Information

3595 John Hopkins Ct

San Diego, California 92121-1331

sequenom.com

(858) 202-9000

NAICS Code : 541710

Recent Events

  • PicksThatMove.com Announces Investment Opinion on Sequenom Inc., Gabriel Resources Ltd., Rentech Inc., Imaging 3 Inc.,...

    11/30/09 - Bond / Stock Rating - View Story

  • Sequenom Q3 Loss Widens - Update

    11/09/09 - Financial Announcement - View Story

  • Sequenom faces fraud suit from Xenomics

    10/30/09 - Lawsuit Filed - View Story

  • Sequenom, Ibis settle lawsuit

    10/27/09 - Legal Settlement - View Story

  • Sequenom names Maier as interim CFO

    10/26/09 - Mgmt. Change Entering - CFO - View Story

  • ATVI, RMBS, MRVL, SQNM, ERIC, AKAM With Highest Daily Short Volume On

    10/12/09 - Joint Venture / Alliance - View Story

  • Sequenom discloses probes following firings

    10/05/09 - Mgmt. Change Leaving - President - View Story

  • Sequenom ousts CEO, other execs

    9/30/09 - Mgmt. Change Entering - Other - View Story

  • Sequenom tumbles after execs fired amid test woes

    9/29/09 - Mgmt. Change Leaving - Other - View Story

  • Investors Remain Hopeful About Sequenom's Prospects

    9/30/09 - Bond / Stock Rating - View Story

  • Sequenom Ousts CEO After Finding Errors, Inconsistencies In Down Syndrome Test; CFO Resigns

    9/29/09 - Mgmt. Change Leaving - Director - View Story

News & Analysis

call transcript and sequenom inc. - All News and Analysis

advertisement
     SQNM $4.24 +0.21 (5.21% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 6,426,500
Shares Outstanding 61.25M
Market Cap 259.7M
Year High 25.99
Year Low 2.55
Earnings Per Share -1.12
P/E Ratio -3.79
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement
Click Here